BIRC5 and cancer: Conditionally replicative recombinant adenoviral vectors encoding dominant-negative survivin mutants have been successfully used to elicit spontaneous and enhanced drug-induced apoptosis in cell lines of different tumor origins and in cancer xenograft models in nude mice.